Werner Milton H.

CIK 00018276211 companyATLANTA, GA

SEC Profile

Transactions

Companies

Filings

CIK

0001827621

Recent Transactions

41 trades

Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−20,834→ 0 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+3,643→ 3,643 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+3,643→ 3,643 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−16,667→ 0 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−45,000→ 0 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−3,643→ 0 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+3,643→ 3,643 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+16,667→ 16,667 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−3,643→ 0 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+35,000→ 35,000 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−3,643→ 0 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+3,643→ 3,643 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+45,000→ 45,000 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−3,643→ 0 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−3,643→ 0 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+3,643→ 3,643 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+20,834→ 20,834 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−35,000→ 0 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-03+5,315,056→ 5,315,056 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-03+2,207,671→ 2,207,671 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-03+4,059,744→ 4,059,744 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (right to buy)
2024-04-01+45,000→ 45,000 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (right to buy)
2023-03-01+210,000→ 210,000 total
Purchase
Inhibikase Therapeutics, Inc.$IKT
Common Stock
2022-08-16$0.80/sh+5,000→ 5,335,433 total
Purchase
Inhibikase Therapeutics, Inc.$IKT
Common Stock
2022-05-27$0.98/sh+5,000→ 5,330,433 total
Purchase
Inhibikase Therapeutics, Inc.$IKT
Common Stock
2022-05-20$0.60/sh+10,000→ 5,325,433 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (right to buy)
2022-03-07+125,000→ 125,000 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (right to buy)
2022-03-07+125,000→ 125,000 total
Exercise/Conversion
Inhibikase Therapeutics, Inc.$IKT
Common Stock
2022-01-03$2.02/sh+21,853→ 5,315,433 total
Exercise/Conversion
Inhibikase Therapeutics, Inc.$IKT
Stock Option (right to buy)
2022-01-03−21,853→ 0 total
Purchase
Inhibikase Therapeutics, Inc.$IKT
Common Stock
2021-11-17$1.93/sh+400→ 23,589 total
Purchase
Inhibikase Therapeutics, Inc.$IKT
Common Stock
2021-11-17$1.94/sh+1,334→ 23,589 total
Purchase
Inhibikase Therapeutics, Inc.$IKT
Common Stock
2021-11-17$1.96/sh+3,186→ 23,589 total
Purchase
Inhibikase Therapeutics, Inc.$IKT
Common Stock
2021-11-17$1.98/sh+17,569→ 23,589 total
Purchase
Inhibikase Therapeutics, Inc.$IKT
Common Stock
2021-11-17$1.97/sh+1,100→ 23,589 total
Exercise/Conversion
Inhibikase Therapeutics, Inc.$IKT
Common Stock
2021-08-17$2.02/sh+21,853→ 5,293,580 total
Exercise/Conversion
Inhibikase Therapeutics, Inc.$IKT
Stock Option (right to buy)
2021-08-17−21,853→ 0 total
Exercise/Conversion
Inhibikase Therapeutics, Inc.$IKT
Common Stock
2021-05-14$0.38/sh+43,707→ 5,288,645 total
Tax Payment
Inhibikase Therapeutics, Inc.$IKT
Common Stock
2021-05-14$4.59/sh−16,918→ 5,271,727 total
Exercise/Conversion
Inhibikase Therapeutics, Inc.$IKT
Stock Option (right to buy)
2021-05-14−43,707→ 0 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (right to buy)
2020-12-22+100,000→ 100,000 total

Companies

Inhibikase Therapeutics, Inc.
Director, President and CEO
$IKT

Recent Filings

Address

3350 RIVERWOOD PARKWAY SE, SUITE 1900

ATLANTA, GA, 30339

View on SEC.gov